Medical Facilities Corporation
Medical Facilities Corporation (MFCSF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Medical Facilities Corporation (MFCSF), featuring income statements, balance sheets, and cash flow data.
Medical Facilities Corporation (MFCSF) Income Statement & Financial Overview
Review Medical Facilities Corporation MFCSF income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $81.71M | $12.52M | $103.57M | $107.17M |
Cost of Revenue | $27.47M | $10.44M | $32.39M | $34.00M |
Gross Profit | $54.24M | $2.09M | $71.19M | $73.18M |
Gross Profit Ratio | $0.66 | $0.17 | $0.69 | $0.68 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $36.97M | -$3.08M | $52.73M | $50.31M |
Operating Expenses | $41.24M | $1.36M | $45.65M | $55.20M |
Total Costs & Expenses | $68.71M | $11.80M | $78.04M | $89.20M |
Interest Income | $1.04M | $1.42M | $144000.00 | $130000.00 |
Interest Expense | $5.20M | -$16.09M | $8.04M | $11.56M |
Depreciation & Amortization | $4.27M | $4.72M | $4.88M | $4.89M |
EBITDA | $18.12M | $6.83M | $30.48M | $22.92M |
EBITDA Ratio | $0.22 | $0.55 | $0.29 | $0.21 |
Operating Income | $13.001M | $725000.00 | $25.54M | $17.98M |
Operating Income Ratio | $0.16 | $0.06 | $0.25 | $0.17 |
Other Income/Expenses (Net) | -$4.34M | $17.52M | -$7.97M | -$11.51M |
Income Before Tax | $8.66M | $18.25M | $17.56M | $6.47M |
Income Before Tax Ratio | $0.11 | $1.46 | $0.17 | $0.06 |
Income Tax Expense | -$321000.00 | -$6.03M | $141000.00 | -$178000.00 |
Net Income | $3.73M | $64.84M | $7.25M | -$370000.00 |
Net Income Ratio | $0.05 | $5.18 | $0.07 | -$0.003 |
EPS | $0.12 | $3.51 | $0.39 | -$0.02 |
Diluted EPS | $0.12 | $2.67 | $0.30 | -$0.02 |
Weighted Avg Shares Outstanding | $22.18M | $18.50M | $18.50M | $18.50M |
Weighted Avg Shares Outstanding (Diluted) | $22.18M | $24.30M | $24.30M | $24.30M |
Over the past four quarters, Medical Facilities Corporation demonstrated steady revenue growth, increasing from $107.17M in Q2 2024 to $81.71M in Q1 2025. Operating income reached $13.001M in Q1 2025, maintaining a consistent 16% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $18.12M, reflecting operational efficiency. Net income dropped to $3.73M, with EPS at $0.12. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan